Showing results (271-280 of 308) with videos related to

Sort By:
Pageof 31
Blood Advances|July 2, 2024
Genetic deletion of JAM-C in preleukemic cells rewires leukemic stem cell gene expression program in AMLJulien M P Grenier, Céline Testut, Matthieu Bal, et al.
The Journal of Clinical Investigation|August 29, 2017
Secreted protein Del-1 regulates myelopoiesis in the hematopoietic stem cell nicheIoannis Mitroulis, Lan-Sun Chen, Rashim Pal Singh, et al.
Stem Cell Reviews and Reports|August 26, 2025
Knock Out of miRNA-30a-5p and Reconstitution of the Actin Network Dynamics Partly Restores the Impaired Terminal Erythroid Differentiation during Blood PharmingJessica Thiel, Duran Sürün, Desiree C Brändle, et al.
Nature Communications|August 29, 2024
Adipocyte deletion of the oxygen-sensor PHD2 sustains elevated energy expenditure at thermoneutralityRongling Wang, Mario Gomez Salazar, Iris Pruñonosa Cervera, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 3, 2025
Targeting miRNA-1a and miRNA-15b: A Novel Combinatorial Strategy to Drive Adult Cardiac RegenerationTing Yuan, Meiqian Wu, Chaonan Zhu, et al.
Blood|December 25, 2012
HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesisKristin Franke, Joanna Kalucka, Soulafa Mamlouk, et al.
Nature Communications|June 8, 2021
The C5a/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from plateletsHenry Nording, Lasse Baron, David Haberthür, et al.
Circulation|March 30, 2019
Inhibition of the Hypoxia-Inducible Factor 1α-Induced Cardiospecific HERNA1 Enhance-Templated RNA Protects From Heart DiseasePeter Mirtschink, Corinne Bischof, Minh-Duc Pham, et al.
British Journal of Pharmacology|October 9, 2025
Leveraging the ADAM10 prodomain for selective inhibition to enhance recovery after myocardial infarctionErik Klapproth, Johanna Marks, Patrick Diaba-Nuhoho, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 4, 2025
A quiescence-like/TGF-β1-specific CRISPRi screen reveals drug uptake transporters as secondary targets of kinase inhibitors in AMLElahe Rahimian, Masoud Koochak, Sofia Traikov, et al.
Pageof 31